Profiel
Magdalena Justyna Przybylo was the founder of Novel-ID Sp zoo, where he held the title of Member-Supervisory Board.
Mr. Przybylo is also the founder of Lipolek Sp zoo.
Actieve functies van Magdalena Justyna Przybylo
| Bedrijven | Functie | Begin |
|---|---|---|
Novel-ID Sp zoo
 Novel-ID Sp zoo Pharmaceuticals: MajorHealth Technology Novel-Id Sp zoo provides solutions in pharmaceutical nanotechnology. It engages in the development and commercialization of innovative solutions in the field of liposome carriers of active substances. The company was founded by Magdalena Justyna Przybylo and Tomasz Pawel Borowik in June 2011 and is headquartered in Krakow, Poland. | Oprichter | 01-06-2011 |
Lipolek Sp zoo
 Lipolek Sp zoo Pharmaceuticals: MajorHealth Technology Lipolek Sp zoo researches and develops pharmaceutical products. The firm manufactures products based on the nanotechnology and offers products such as anticoagulant in a form of liposome gel. The company is headquartered in Warsaw, Poland. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Lipolek Sp zoo
Lipolek Sp zoo Pharmaceuticals: MajorHealth Technology Lipolek Sp zoo researches and develops pharmaceutical products. The firm manufactures products based on the nanotechnology and offers products such as anticoagulant in a form of liposome gel. The company is headquartered in Warsaw, Poland. | Health Technology |
Novel-ID Sp zoo
Novel-ID Sp zoo Pharmaceuticals: MajorHealth Technology Novel-Id Sp zoo provides solutions in pharmaceutical nanotechnology. It engages in the development and commercialization of innovative solutions in the field of liposome carriers of active substances. The company was founded by Magdalena Justyna Przybylo and Tomasz Pawel Borowik in June 2011 and is headquartered in Krakow, Poland. | Health Technology |
